Immediate Impact
73 standout
Citing Papers
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
2021 Standout
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy
2020 Standout
Works of W Klein being referenced
The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): Rationale, Design and End-Points
2001
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| W Klein | 332 | 104 | 19 | 52 | 11 | 381 | |
| Michihiro Yoshimura | 255 | 61 | 31 | 87 | 11 | 342 | |
| Andrew E. Epstein | 420 | 48 | 21 | 18 | 13 | 453 | |
| Hugues Bader | 377 | 42 | 12 | 48 | 8 | 390 | |
| Miles J. Schwartz | 278 | 67 | 58 | 78 | 17 | 408 | |
| Panayota Flevari | 352 | 78 | 12 | 16 | 16 | 382 | |
| Donna M. Gallik | 323 | 57 | 13 | 72 | 16 | 391 | |
| David W. Baron | 362 | 165 | 60 | 64 | 16 | 432 | |
| Walter F. Kerwin | 420 | 47 | 7 | 30 | 9 | 430 | |
| Angelica Fundaliotis | 317 | 37 | 20 | 21 | 17 | 338 | |
| Dirk van Osch | 352 | 81 | 14 | 44 | 13 | 386 |
All Works
Loading papers...